Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Elford

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Anticancer Research|December 31, 1997
DNA-protective activity of new ribonucleotide reductase inhibitorsP Rauko, D Romanova, E Miadokova, et al.
Advances in Enzyme Regulation|January 1, 1980
Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agentsH L Elford, B Van't Riet, G L Wampler, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Antimalarial activities of polyhydroxyphenyl and hydroxamic acid derivativesK P Holland, H L Elford, V Bracchi, et al.
Experimental Hematology|September 16, 2000
Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cellsM Fritzer-Szekeres, M Grusch, C Luxbacher, et al.
Cancer Biology & Therapy|December 24, 2002
Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3Mohammed S Inayat, Damodaran Chendil, Mohammed Mohiuddin, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2004
Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cellsZsuzsanna Horvath, Thomas Höchtl, Wolfgang Bauer, et al.
Advances in Experimental Medicine and Biology|January 11, 2002
Apoptosis-inducing cleavage of caspases by trimidox, an inhibitor of ribonucleotide reductaseM Fritzer-Szekeres, C Luxbacher, Z Horvath, et al.
Stem Cells (Dayton, Ohio)|December 22, 1999
In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activityC N Mayhew, J D Phillips, R N Greenberg, et al.
Comparative Medicine|December 26, 2009
Ribonucleotide reductase inhibitors reduce atherosclerosis in a double-injury rabbit modelLaura D Gallaugher, Jon C Henry, Patrick N Kearns, et al.
Life Sciences|December 23, 2003
Biochemical modulation of Ara-C effects by amidox, an inhibitor of ribonucleotide reductase in HL-60 promyelocytic human leukemia cellsThomas Höchtl, Zsuzsanna Horvath, Wolfgang Bauer, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Anticancer Research|December 31, 1997
DNA-protective activity of new ribonucleotide reductase inhibitorsP Rauko, D Romanova, E Miadokova, et al.
Advances in Enzyme Regulation|January 1, 1980
Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agentsH L Elford, B Van't Riet, G L Wampler, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Antimalarial activities of polyhydroxyphenyl and hydroxamic acid derivativesK P Holland, H L Elford, V Bracchi, et al.
Experimental Hematology|September 16, 2000
Trimidox, an inhibitor of ribonucleotide reductase, induces apoptosis and activates caspases in HL-60 promyelocytic leukemia cellsM Fritzer-Szekeres, M Grusch, C Luxbacher, et al.
Cancer Biology & Therapy|December 24, 2002
Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3Mohammed S Inayat, Damodaran Chendil, Mohammed Mohiuddin, et al.
Cancer Chemotherapy and Pharmacology|May 11, 2004
Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cellsZsuzsanna Horvath, Thomas Höchtl, Wolfgang Bauer, et al.
Advances in Experimental Medicine and Biology|January 11, 2002
Apoptosis-inducing cleavage of caspases by trimidox, an inhibitor of ribonucleotide reductaseM Fritzer-Szekeres, C Luxbacher, Z Horvath, et al.
Stem Cells (Dayton, Ohio)|December 22, 1999
In vivo and in vitro comparison of the short-term hematopoietic toxicity between hydroxyurea and trimidox or didox, novel ribonucleotide reductase inhibitors with potential anti-HIV-1 activityC N Mayhew, J D Phillips, R N Greenberg, et al.
Comparative Medicine|December 26, 2009
Ribonucleotide reductase inhibitors reduce atherosclerosis in a double-injury rabbit modelLaura D Gallaugher, Jon C Henry, Patrick N Kearns, et al.
Life Sciences|December 23, 2003
Biochemical modulation of Ara-C effects by amidox, an inhibitor of ribonucleotide reductase in HL-60 promyelocytic human leukemia cellsThomas Höchtl, Zsuzsanna Horvath, Wolfgang Bauer, et al.
Pageof 7